Acta Neuropathologica

, Volume 109, Issue 1, pp 25–31

Metabolic/signal transduction hypothesis of Alzheimer’s disease and other tauopathies

Review
  • 210 Downloads

Abstract

Alzheimer’s disease (AD), the major cause of dementia in middle- to old-aged individuals, is multifactorial. Independent of the etiology, whether genetic or non-genetic, this disease is characterized by extracellular β-amyloid plaques and intraneuronal neurofibrillary tangles of abnormally hyperphosphorylated tau. However, the molecular mechanisms of neither AD nor other tauopathies are completely understood. To date, the most popular hypothesis of AD is the “Amyloid cascade hypothesis”, according to which β-amyloid, the cleavage product of β-amyloid precursor protein (APP), is neurotoxic and causes neurodegeneration and dementia. However, this hypothesis is inconsistent with the presence in normal aged human brain of the β-amyloid plaque burden similar to that in AD, and the absence of neurofibrillary pathology and neurodegeneration in mutated APP, presenilin-1 and presenilin-2 transgenic mice that show extensive β-amyloid plaque pathology. Here we propose an alternate hypothesis, the “Metabolic/signal transduction hypothesis”, which is consistent both with the pathology seen in AD and other tauopathies and as well as all experimental animal conditions. In this hypothesis, with increasing age, the fluidity of neuronal membranes is progressively reduced, which makes it less resistant to environmental/metabolic insults affecting one or more signal transduction pathways, which lead to a protein phosphorylation/dephosphorylation imbalance and abnormal hyperphosphorylation of tau. The hyperphosphorylated tau sequesters normal tau, MAP1 and MAP2, which results in breakdown of the microtubule network and, consequently, a progressive retrograde degeneration of the affected neurons and, ultimately, dementia.

Keywords

Alzheimer’s disease Tauopathies Microtubule-associated protein tau Neurofibrillary degeneration Signal transduction 

References

  1. 1.
    Alonso A del C, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 91:5562–5566Google Scholar
  2. 2.
    Alonso A del C, Grundke-Iqbal I, Iqbal K (1996) Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2:783–787Google Scholar
  3. 3.
    Alonso A del C, Grundke-Iqbal I, Barra HS, Iqbal K (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of MAP1 and MAP2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA. 94:298–303Google Scholar
  4. 4.
    Alonso A del C, Zaidi T, Wu Q, Novak M, Barra HS, Grundke-Iqbal I, Iqbal K (2001) Interaction of tau isoforms with Alzheimer’s disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J Biol Chem 276:37967–37973CrossRefPubMedGoogle Scholar
  5. 5.
    Alonso A del C, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98:6923–6928Google Scholar
  6. 6.
    Alonso A del C, Mederlyova A, Novak M, Grundke-Iqbal I, Iqbal K (2004) Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 279:34878–34881Google Scholar
  7. 7.
    Arnold CS, Johnson GV, Cole RN, Dong DL, Lee M, Hart GW (1996) The microtubule-associated protein tau is extensively modified with O-linked N0-acetylglucosamine. J Biol Chem 271:28741–28744CrossRefPubMedGoogle Scholar
  8. 8.
    Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84:361–384CrossRefGoogle Scholar
  9. 9.
    Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477:90–99PubMedGoogle Scholar
  10. 10.
    Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K (2001) Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett 490:15–22CrossRefGoogle Scholar
  11. 11.
    Cho JH, Johnson GV (2003) Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J Biol Chem 278:187–193CrossRefGoogle Scholar
  12. 12.
    Cho JH, Johnson GV (2004) Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau’s ability to bind and stabilize microtubules. J Neurochem 88:349–358Google Scholar
  13. 13.
    Chohan M, Haque N, Alonso A del C, El-Akkad E, Grundke-Iqbal I, Grover A, Iqbal K. (2004) Hyperphosphorylation-induced self-assembly of murine tau: a comparison with human tau. J Neural Transm (in press)Google Scholar
  14. 14.
    Coria F, Castaño B, Frangione B (1987) Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer’s disease beta-protein. Am J Pathol 129:422–428PubMedGoogle Scholar
  15. 15.
    Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003) Aberrant cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40:471–483CrossRefGoogle Scholar
  16. 16.
    Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH (1988) Alzheimer’s disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol 132:86–101PubMedGoogle Scholar
  17. 17.
    Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson M (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179–189CrossRefPubMedGoogle Scholar
  18. 18.
    Finch C, Tanzi RE (1997) Genetics of aging. Science 278:407–411CrossRefPubMedGoogle Scholar
  19. 19.
    Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perrini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Busiani O, Giaccone G, Prelli F, Goedert M. Dlouhy SR, Tagliavini F (1996) Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 93:744–748Google Scholar
  20. 20.
    Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3:519–526CrossRefPubMedGoogle Scholar
  21. 21.
    Götz J. Chen F, Dorpe J van, Nitsch RM (2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491–1495CrossRefPubMedGoogle Scholar
  22. 22.
    Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau: a component of Alzheimer paired helical filaments. J Biol Chem 261:6084-6089PubMedGoogle Scholar
  23. 23.
    Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 93:4913-4917Google Scholar
  24. 24.
    Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185PubMedGoogle Scholar
  25. 25.
    Hart GW (1997) Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins Annu Rev Biochem 66:315–335Google Scholar
  26. 26.
    Holcomb L, Gordon MN, McGowan E, Xu Y, Benkovic S, Jantzen P et al (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97–100Google Scholar
  27. 27.
    Hutton M, Lendon CL, Rizsazu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, et al (1998) Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702–705CrossRefPubMedGoogle Scholar
  28. 28.
    Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, Winblad B (1986) Defective brain microtubule assembly in Alzheimer’s disease. Lancet II:421-426CrossRefGoogle Scholar
  29. 29.
    Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, Zaidi T (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease Proc Natl Acad Sci USA 86:5646-5650Google Scholar
  30. 30.
    Iqbal K, Zaidi T, Bancher C, Grundke-Iqbal I (1994) Alzheimer paired helical filaments: restoration of the biological activity by dephosphorylation. FEBS Lett 349:104–108CrossRefPubMedGoogle Scholar
  31. 31.
    Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, Davies P (1999) cAMP-dependent protein kinase phosphorylations on tau in Alzheimer’s disease. J Neurosci 19:486–494Google Scholar
  32. 32.
    Katzman R, Terry RD, DeTeresa R, Brown R, Davies P, Fuld P, Renling X, Peck A (1988) Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138–144PubMedGoogle Scholar
  33. 33.
    Khatoon S, Grundke-Iqbal I, Iqbal K (1992) Brain levels of microtubule associated protein tau are elevated in Alzheimer’s disease brain: a radioimmunoslot-blot assay for nanograms of the protein J Neurochem 59:750–753Google Scholar
  34. 34.
    Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351:80–84CrossRefPubMedGoogle Scholar
  35. 35.
    Köpke E, Tung YC, Shaikh S, Alonso A del C, Iqbal K, Grundke-Iqbal I (1993) Microtubule associated protein tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease J Biol Chem 268:24374–24384Google Scholar
  36. 36.
    Lau LF, Schachter JB, Seymour PA, Sanner MA (2002) Tau protein phosphorylation as a therapeutic target in Alzheimer’s disease. Curr Top Med Chem 2:395–415Google Scholar
  37. 37.
    Lee VMY, Balin BJ, Otvos L Jr, Trojanowski JQ, (1991) A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675–678PubMedGoogle Scholar
  38. 38.
    Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, Duinen SG van, Bots GT, Luyendijk W, Frangione B (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124–1126PubMedGoogle Scholar
  39. 39.
    Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Murphy MP, Baker M, Yu X, Duff K, Hardy J, Corrall A, Lin WL, Yen SH, Dickson DW, Davies DW, Hutton M. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25:402–405Google Scholar
  40. 40.
    Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491CrossRefPubMedGoogle Scholar
  41. 41.
    Liu F, Zaidi T, Grundke-Iqbal I, Iqbal K, Gong CX (2002) Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5. Neuroscience 115:829–837Google Scholar
  42. 42.
    Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2002) Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3β. FEBS Lett 530:209–214CrossRefPubMedGoogle Scholar
  43. 43.
    Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX (2004) O-GlcNAcylation regulates phosphorylation of tau: a novel mechanism involved in Alzheimer’s disease. Proc Natl Acad Sci USA 101:10804–10809Google Scholar
  44. 44.
    Liu SJ, Zhang JY, Li HL, Fang ZY, Wang Q, Deng HM, Gong CX, Grundke-Iqbal I, Iqbal K, Wang JZ (2004) Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain. J Biol Chem 279:50078–50088Google Scholar
  45. 45.
    Mah VH, Eskin TA, Kazee AM, Lapham L, Higgins GA (1992) In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer’s disease. Brain Res Mol Brain Res 12:85–94CrossRefPubMedGoogle Scholar
  46. 46.
    Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58:188–197PubMedGoogle Scholar
  47. 47.
    Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409–421CrossRefPubMedGoogle Scholar
  48. 48.
    Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43:321–332CrossRefGoogle Scholar
  49. 49.
    Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43:815–825PubMedGoogle Scholar
  50. 50.
    Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Annu Rev Med 47:387–400CrossRefPubMedGoogle Scholar
  51. 51.
    Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K (1998) Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys 357:299–309CrossRefGoogle Scholar
  52. 52.
    Sironi JJ, Yen SH, Gondal JA, Wu Q, Grundke-Iqbal I, Iqbal K (1998) Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK. FEBS Lett 436:471–475CrossRefGoogle Scholar
  53. 53.
    Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95:7737–7741Google Scholar
  54. 54.
    Tanemura K, Akagi T, Murayama M, Kikuchi N, Murayama O, Hashikawa T, Yoshiike Y, Park JM, Matsuda K, Nakao S, Sun X, Sato S, Yamaguchi H, Takashima A (2001) Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Neurobiol Dis 8:1036–1045CrossRefPubMedGoogle Scholar
  55. 55.
    Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, Iwasaki K, Fujiwara M, Tanemura K, Murayama M, Ishiguro K, Planel E, Sato S, Hashikawa T, Takashima A (2002) Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc Natl Acad Sci USA 99:13896–13901Google Scholar
  56. 56.
    Tolnay M, Probst A (2003) The neuropathological spectrum of neurodegenerative tauopathies. IUBMB Life 55:299–305Google Scholar
  57. 57.
    Van Duinen SG, Castanol EM, Prelli F, Bots GT, Luyendijk W, Frangione B (1987) Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Natl Acad Sci USA 84:5991–5994Google Scholar
  58. 58.
    Wang JZ, Gong CX, Zaidi T, Grundke-Iqbal I, Iqbal K (1995) Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem 270:4854–4860CrossRefPubMedGoogle Scholar
  59. 59.
    Wang JZ, Grundke-Iqbal I, Iqbal K (1996) Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer’s disease. Nat Med 2:871–875Google Scholar
  60. 60.
    Wang JZ, Grundke-Iqbal I, Iqbal K (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res Mol Brain Res 38:200–208CrossRefGoogle Scholar
  61. 61.
    Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72:1858–1862Google Scholar
  62. 62.
    Zheng-Fischhofer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem 252:542–555CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  1. 1.Department of NeurochemistryNew York State Institute for Basic Research In Developmental DisabilitiesStaten IslandUSA

Personalised recommendations